Fine Chemicals: Growth Slows for Drugs and APIs

Global spending on medicines will reach almost $1.1 trillion by 2015, reflecting a slowing compound annual growth rate (CAGR) of 3%-6% over the next five years, says consulting firm IMS Health (Danbury, CT). That compares with 6.2% annual growth over the past five years. Lower levels of spending growth for medicines in the U.S., the ongoing impact of patent expiries in developed markets, continuing strong demand in emerging markets, and policy-driven changes in several countries are among the key factors that will influence future growth, IMS Health says. The...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers